Search filters

List of works by Ulf Andreasson

A Practical Guide to Immunoassay Method Validation

scientific article

A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease

scientific article

Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders

scientific article published in November 2012

Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography

scientific article

Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs

scientific article published on January 2010

Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate

scientific article published on 8 May 2017

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

scientific article

Amyloid-β metabolism in Niemann-Pick C disease models and patients

scientific article

Amyloid-β(1-15/16) as a marker for γ-secretase inhibition in Alzheimer's disease

scientific article published on January 2012

An Alzheimer's disease-specific beta-amyloid fragment signature in cerebrospinal fluid

scientific article published on 17 October 2006

Analytical aspects of molecular Alzheimer's disease biomarkers

scientific article published on August 2012

Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease

scientific article published in October 2014

Aspects of beta-amyloid as a biomarker for Alzheimer's disease

scientific article published on June 2007

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease

scientific article published on 27 March 2017

Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases

scientific article

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease

scientific article

BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system

scientific article

Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving

scientific article published on 7 July 2016

Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder

scientific article published on 08 February 2017

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment

scientific article

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

scientific article published on 16 June 2015

C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning

scientific article

CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation

scientific article

CSF Aβ42 predicts early-onset dementia in Parkinson disease

scientific article published on 18 April 2014

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study

scientific article

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

scientific article published on 8 April 2016

CSF antithrombin III and disruption of the blood-brain barrier

scientific article published on 30 March 2009

CSF biomarker variability in the Alzheimer's Association quality control program

scientific article published on May 2013

CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease

scientific article published in January 2010

Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change

scientific article published on 20 November 2017

Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease ⬇️

scientific article published on January 1, 2011

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease

scientific article

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection

scientific article

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease

scientific article

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

scientific article published on 27 October 2017

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

scientific article published in January 2011

Cerebrospinal fluid biomarkers in cardiac arrest survivors

scientific article

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study

scientific article published on July 2013

Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

article

Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women

scientific article published on 30 April 2016

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

scientific article published in December 2014

Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies

scientific article published in March 2017

Cerebrospinal fluid microglial markers in Alzheimer's disease: elevated chitotriosidase activity but lack of diagnostic utility

scientific article published on 13 May 2011

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease

scientific article

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease

scientific article published on 18 February 2012

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

scientific article

Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease

scientific article published on 7 October 2015

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry

scientific article

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

scientific article published on July 2015

Circulating levels of vascular endothelial growth factor and post-stroke long-term functional outcome

scientific article published on 22 January 2020

Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".

scientific article

Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics

scientific article published in March 2016

Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

scientific article published on 12 April 2016

Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease

scientific article published in January 2013

Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid

scientific article

Converging pathways of chromogranin and amyloid metabolism in the brain

scientific article published on January 2010

Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].

scientific article published on 20 April 2016

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases

scientific article

Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis

scientific article published on 26 September 2015

Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

scientific article

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

scientific article

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease

scientific article

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

scientific article

Evaluation of the Performance of Novel Aβ Isoforms as Theragnostic Markers in Alzheimer’s Disease: From the Cell to the Patient ⬇️

scientific article published on January 1, 2012

Explorative and targeted neuroproteomics in Alzheimer's disease

scientific article

Exploring Alzheimer molecular pathology in Down's syndrome cerebrospinal fluid

scientific article published on 27 June 2014

Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice

scientific article published on 25 November 2014

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

scientific article published on 25 June 2009

Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease

scientific article published on 26 August 2015

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease

scientific article published on May 2016

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

scientific article

Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment

scientific article

Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke

scientific article published on 14 June 2016

Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease

scientific article

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid

scientific article

Measurement of Aβ1–42 in cerebrospinal fluid is influenced by matrix effects ⬇️

scientific article published on November 28, 2011

Multiplexing and multivariate analysis in neurodegeneration

scientific article published on 25 February 2012

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease

scientific article

Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study

scientific article published on 9 March 2018

No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.

scientific article published on 07 September 2016

Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment

scientific article published on January 2011

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

scientific article published on 22 November 2015

Plasma tau in Alzheimer disease

scientific article published on 30 September 2016

Plasma tau levels in Alzheimer's disease

scientific article published on 28 March 2013

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment

scientific article published on 19 March 2007

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems

scientific article published on 13 April 2018

Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers

scientific article published on August 2012

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

scientific article

Proteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases

scientific article published on January 2009

Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease

scientific article

Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment

scientific article

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

scientific article published on 31 August 2016

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

scientific article published on August 2012

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease ⬇️

scientific article published on January 14, 2011

Serum Neurofilament Light in American Football Athletes Over the Course of a Season

scientific article published on 23 December 2015

Serum erythropoietin and outcome after ischaemic stroke: a prospective study

scientific article published on 25 February 2016

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury

scientific article

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

scientific article

Subcortical vascular dementia biomarker pattern in mild cognitive impairment

scientific article published on 27 October 2009

Targeted proteomics in Alzheimer's disease: focus on amyloid-beta

scientific article published on April 2008

Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid

scientific article published on 7 November 2015

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

scientific article published on July 2011

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology

scientific article (publication date: 26 April 2017)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders

scientific article

β-site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces Aβ5-X peptides through alternative amyloid precursor protein cleavage

scientific article published on 17 November 2014

Paulina is supported by:

About Paulina

Help